Sort by
Refine Your Search
-
PhD Studentship - Marie Curie network MetaExplore: Functional metagenomics - novel biocatalysts for a sustainable circular economy from ultrahigh throughput screening. A postdoctoral position is
-
Location: West Cambridge Funder: Tata Steel and the University of Cambridge Duration: 4 years from 1 October 2026 Supervisors: Prof Howard Stone and Dr David Collins Location: The PhD studentship
-
: The PhD studentship will be based at the University of Cambridge in the Department of Materials Science and Metallurgy as part of the Structural Materials Group. The Structural Materials Group is a diverse
-
This is a four-year (1+3 MRes/PhD) studentship funded through the Cambridge EPSRC Centre for Doctoral Training in Future Infrastructure and Built Environment: Unlocking Net Zero (FIBE3 CDT). Further
-
and Technology (CST) at the University of Cambridge. The goal of this PhD programme is to launch one "deceptive by design" project that combines the perspectives of human-computer interaction (HCI) and
-
) advances in imaging techniques that fuel a more detailed understanding of the brain, 2) tools from artificial intelligence that enable building better computer simulations of the brain. The lab will leverage
-
The PhD studentship will be based at the University of Cambridge in the Department of Materials Science and Metallurgy as part of the Structural Materials Group. The Structural Materials Group is a
-
Location: West Cambridge Funder: Tata Steel and the University of Cambridge Duration: 4 years from 1 October 2026 Supervisors: Prof Howard Stone and Dr David Collins Location: The PhD studentship
-
biostatistics. We develop, apply and promote innovative statistical and data science approaches to advance biomedical science and human health. The BSU current research portfolio is organised into five main
-
Department/Location: Yusuf Hamied Department of Chemistry Applications are invited for a 4-year PhD studentship based in the Department of Chemistry, University of Cambridge and the new AstraZeneca